Federico Alghisi

699 total citations
38 papers, 373 citations indexed

About

Federico Alghisi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Epidemiology. According to data from OpenAlex, Federico Alghisi has authored 38 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Federico Alghisi's work include Cystic Fibrosis Research Advances (23 papers), Neonatal Respiratory Health Research (6 papers) and Pancreatitis Pathology and Treatment (5 papers). Federico Alghisi is often cited by papers focused on Cystic Fibrosis Research Advances (23 papers), Neonatal Respiratory Health Research (6 papers) and Pancreatitis Pathology and Treatment (5 papers). Federico Alghisi collaborates with scholars based in Italy, United States and Netherlands. Federico Alghisi's co-authors include V. Lucidi, Lidia Monti, Sergio Bella, Adriano Angioni, Melania Manco, Maria Rosaria D’Apice, Giuseppe Novelli, Enza Montemitro, Manuela Onori and Gabriella Ricciotti and has published in prestigious journals such as CHEST Journal, The Journal of Infectious Diseases and European Respiratory Journal.

In The Last Decade

Federico Alghisi

32 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Federico Alghisi Italy 11 154 134 68 45 37 38 373
Isabelle Scheers Belgium 14 79 0.5× 266 2.0× 84 1.2× 95 2.1× 19 0.5× 44 532
S. M. Hamilton United States 12 73 0.5× 58 0.4× 53 0.8× 28 0.6× 20 0.5× 17 402
Imran Nizami Saudi Arabia 11 149 1.0× 47 0.4× 57 0.8× 22 0.5× 17 0.5× 25 273
Toshifumi Saito Japan 11 146 0.9× 231 1.7× 87 1.3× 44 1.0× 94 2.5× 36 581
Danail Petrov Bulgaria 10 198 1.3× 144 1.1× 23 0.3× 50 1.1× 6 0.2× 46 410
PLC TISDALL Australia 12 70 0.5× 174 1.3× 139 2.0× 8 0.2× 16 0.4× 16 362
Giulia Angelino Italy 11 98 0.6× 119 0.9× 56 0.8× 27 0.6× 82 2.2× 25 345
Ahmet Dobrucalı Türkiye 14 111 0.7× 357 2.7× 112 1.6× 24 0.5× 126 3.4× 31 537
Fernando Tuffi García Colombia 9 150 1.0× 315 2.4× 22 0.3× 22 0.5× 44 1.2× 15 469
Marilina Nantron Italy 12 96 0.6× 71 0.5× 69 1.0× 28 0.6× 4 0.1× 18 413

Countries citing papers authored by Federico Alghisi

Since Specialization
Citations

This map shows the geographic impact of Federico Alghisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Alghisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Alghisi more than expected).

Fields of papers citing papers by Federico Alghisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Alghisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Alghisi. The network helps show where Federico Alghisi may publish in the future.

Co-authorship network of co-authors of Federico Alghisi

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Alghisi. A scholar is included among the top collaborators of Federico Alghisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Alghisi. Federico Alghisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Faraci, Simona, Federico Alghisi, Claudio Romano, et al.. (2026). ERCP-based management of pediatric chronic pancreatitis: Results from a retrospective long-term multicentric study. Digestive and Liver Disease.
2.
Cappa, Marco, Fabiana Ciciriello, Fabio Majo, et al.. (2025). Height Velocity in Pediatric Cystic Fibrosis Under Triple CFTR Modulator Therapy: A Real-Life Monocentric Experience. Journal of Clinical Medicine. 14(15). 5259–5259.
3.
Poerio, Noemi, Nicola Ivan Lorè, Fabiana Ciciriello, et al.. (2025). Phosphatidylinositol 5-Phosphate-Loaded Apoptotic Body-Like Liposomes for Mycobacterium abscessus Infection Management in Patients With Cystic Fibrosis. The Journal of Infectious Diseases. 232(1). e43–e47.
4.
Ciciriello, Fabiana, Nicolò de Pretis, Laura Bernardoni, et al.. (2024). CFTR function is impaired in a subset of patients with pancreatitis carrying rare CFTR variants. Pancreatology. 24(3). 394–403.
5.
Graziano, Silvia, Fabio Majo, Enza Montemitro, et al.. (2023). P082 Is the new modulator affecting global health outcomes over time?. Journal of Cystic Fibrosis. 22. S88–S88. 1 indexed citations
6.
Foppiani, Andrea, Fabiana Ciciriello, Carla Colombo, et al.. (2023). Distribution of OGTT-Related Variables in Patients with Cystic Fibrosis from Puberty to Adulthood: An Italian Multicenter Study. Journal of Personalized Medicine. 13(3). 469–469.
7.
Colombo, Carla, Grant A. Ramm, Anders Lindblad, et al.. (2023). Characterization of CFTR mutations in people with cystic fibrosis and severe liver disease who are not eligible for CFTR modulators. Journal of Cystic Fibrosis. 22(2). 263–265. 4 indexed citations
8.
Boldrini, Francesca, Gaia Romana Pellicano, Fabio Majo, et al.. (2023). Longitudinal Effects of Elexacaftor/Tezacaftor/Ivacaftor. CHEST Journal. 165(4). 800–809. 17 indexed citations
9.
Manco, Melania, Alessandro Fiocchi, Manuela Bartoli, et al.. (2022). An inflammatory Signature of Glucose Impairment in Cystic Fibrosis. Journal of Inflammation Research. Volume 15. 5677–5685. 3 indexed citations
10.
Ciciriello, Fabiana, et al.. (2022). Lived experiences of people with cystic fibrosis that were not eligible for elexacaftor-tezacaftor-ivacaftor (ETI): A qualitative study. Journal of Cystic Fibrosis. 22(3). 414–419. 6 indexed citations
11.
Ciciriello, Fabiana, Marcel J. C. Bijvelds, Federico Alghisi, et al.. (2022). Theratyping of the Rare CFTR Variants E193K and R334W in Rectal Organoid-Derived Epithelial Monolayers. Journal of Personalized Medicine. 12(4). 632–632. 16 indexed citations
12.
Colombo, Carla, Gianfranco Alicandro, Mark Oliver, et al.. (2021). Ursodeoxycholic acid and liver disease associated with cystic fibrosis: A multicenter cohort study. Journal of Cystic Fibrosis. 21(2). 220–226. 21 indexed citations
13.
Buzzetti, Roberto, Natalia Cirilli, Fabio Majo, et al.. (2018). Defining research priorities in cystic fibrosis. Can existing knowledge and training in biomedical research affect the choice?. Journal of Cystic Fibrosis. 18(3). 378–381. 4 indexed citations
14.
Sofia, Valentina, Letizia Da Sacco, Cecilia Surace, et al.. (2016). Extensive Molecular Analysis Suggested the Strong Genetic Heterogeneity of Idiopathic Chronic Pancreatitis. Molecular Medicine. 22(1). 300–309. 18 indexed citations
15.
Sofia, Valentina, Cecilia Surace, Fabio Majo, et al.. (2015). Relationship between CFTR and CTRC Variants and the Clinical Phenotype in Late-Onset Cystic Fibrosis Disease with Chronic Pancreatitis. Journal of Molecular Diagnostics. 17(2). 171–178. 6 indexed citations
16.
17.
Bizzarri, Carla, Germana Giannone, Enza Montemitro, et al.. (2013). ZnT8 antibodies in patients with cystic fibrosis: An expression of secondary beta-cell damage?. Journal of Cystic Fibrosis. 12(6). 803–805. 7 indexed citations
18.
Cilli, Mirella, et al.. (2011). [Economic evaluation of telehomecare in chronic lung diseases].. PubMed. 162(2). e43–9. 7 indexed citations
19.
20.
Alghisi, Federico, Adriano Angioni, Maria Rosaria D’Apice, et al.. (2008). Diagnosis of atypical CF: A case-report to reflect. Journal of Cystic Fibrosis. 7(4). 292–294. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabelle Scheers Breakdown of academic impact, for papers by S. M. Hamilton Breakdown of academic impact, for papers by Imran Nizami Breakdown of academic impact, for papers by Toshifumi Saito Breakdown of academic impact, for papers by Danail Petrov Breakdown of academic impact, for papers by PLC TISDALL Breakdown of academic impact, for papers by Giulia Angelino Breakdown of academic impact, for papers by Ahmet Dobrucalı Breakdown of academic impact, for papers by Fernando Tuffi García Breakdown of academic impact, for papers by Marilina Nantron
Rankless by CCL
2026